Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV
Discussion:
BZD use may elevate risk for NCI in PLWH, potentially through diffuse neurocognitive slowing and acute compromise of recall and higher-order capacities. These effects are robust to psychosocial and HIV-specific factors and occur in comparison with a tightly matched BZD− group. Prospective and interventional studies should evaluate causal associations between NCI and BZD use and explore treatment alternatives to BZDs in PLWH.
Source: JAIDS Journal of Acquired Immune Deficiency Syndromes - Category: Infectious Diseases Tags: Clinical Science Source Type: research
More News: Alprazolam | Ativan | Brain | Diazepam | Infectious Diseases | Lorazepam | Neurology | Neuroscience | Science | Study | Toxicology | Valium | Xanax